enbucrilate has been researched along with Urinary Bladder Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berry, C; Brown, K; Chao, M; Duncan, C; Foroudi, F; Jenkins, T; Joon, DL; Khoo, V; Lawlor, M; Lawrentschuk, N; O'Meara, R; Schneider, M; Sengupta, S; Viotto, A; Wada, M | 1 |
| Bruttini, GP; Fasce, L; Nadalini, V; Piccardo, M; Positano, N | 1 |
2 other study(ies) available for enbucrilate and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Fiducial markers: can the urologist do better?
Topics: Animals; Cone-Beam Computed Tomography; Cyanoacrylates; Cystoscopy; Diatrizoate Meglumine; Enbucrilate; Ethiodized Oil; Feasibility Studies; Fibrin Tissue Adhesive; Fiducial Markers; Radiotherapy, Image-Guided; Swine; Tissue Adhesives; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2019 |
[Arterial complications during therapeutic vesicorenal embolizations (author's transl)].
Topics: Aged; Embolization, Therapeutic; Enbucrilate; Hemorrhage; Humans; Infarction; Kidney; Kidney Neoplasms; Male; Middle Aged; Renal Artery; Urinary Bladder Neoplasms | 1980 |